No Data
No Data
Express News | "Weight-Loss Drug Craze Appears To Be Curbing U.S. Obesity Epidemic; Obesity Is Down In The U.S. For The First Time In A Decade. A New Study Suggests Weight-Loss Drugs May Explain Why" - Bloomberg News
Ozempic Works on Kidney Disease, Regulator Says. Why Novo Nordisk Stock Is Falling.
Viking Engineering Laboratory Achieves ISO 17025 Accreditation
10 Health Care Stocks With Whale Alerts In Today's Session
The Zacks Analyst Blog Eli Lilly, Novo Nordisk's Amgen and Viking Therapeutics
Promising Prospects for Viking Therapeutics' VK2735 in Obesity Treatment: A Buy Rating With $125 Price Target
loading...
74529537 : Waiting is so hard.